Jeff L Vacirca has bought stock on 2 days since Mar 2019

Jeffrey Vacirca, MD, FACP

Jeffrey Vacirca, MD, FACP, is a board-certified hematologist and oncologist who has served as CEO and Chairman of the Board of New York Cancer & Blood Specialists (NYCBS), a leading cancer care center specializing in hematology/oncology, since 2008.( He currently serves as an independent director on the Board of Directors of Caris Life Sciences, Inc. (CAI), appointed effective November 7, 2024,( and holds the role of Medical Director for Oncology Network Development at Mount Sinai Health Network since 2018, along with serving as an associate clinical professor at Icahn School of Medicine at Mount Sinai.( An entrepreneurial leader in oncology, Dr. Vacirca co-founded OneOncology and Odonate Therapeutics (2016-2019), formed the Conquering Cancer PAC, and has provided early funding to companies like Cedar, Thyme Care, and Sherpa Health.(

Dr. Vacirca's career highlights include past presidency of the Community Oncology Alliance, service on its executive committee, and prior board roles at public companies such as Assertio Holdings (2023-2024), Spectrum Pharmaceuticals (2018-2023), and BeyondSpring Inc. (2020-2022).( He also served on Caris Life Sciences' Scientific Advisory Board from 2014 to 2020 and is founder and Chairman of the New York Cancer Foundation.( He earned his medical degree from St. George's University School of Medicine and completed residency and fellowship at State University of New York in Stony Brook.(

Written by Perplexity from public sources.